Company: MBIO
Filing Date: 2025-02-13
Form Type: 424B3
Source: 0001104659-25-013030
Chunk: 6

Company: MUSTANG BIO, INC.
Filing Date: 2025-02-13
Form: 424B3
Chunk 6
---
 forth in Item 1.01 of this Current Report on Form 8-K are incorporated into this Item 1.02 by reference with respect
to the termination of the Lease pursuant to the Amendment.

Cautionary Note Regarding Forward-looking Statements

This
Current Report on Form 8-K contains predictive or “forward-looking statements” within the meaning of the Private Securities
Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this Current Report on
Form 8-K, including statements that express the Company’s intentions, plans, objectives, beliefs, expectations, strategies, predictions
or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words
“anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,”
“intend,” “may,” “plan,” “predict,” “project,” “will,” “should,”
“would” and similar expressions are intended to identify forward-looking statements. These statements are based on current
expectations, estimates and projections made by management about the Company’s business, industry and other conditions affecting
its financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve
risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from
what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties, including
the risks that any of the conditions in the Sale/Surrender Agreement, Escrow Agreement or Amendment are not satisfied and those risks
and uncertainties described in the filings the Company makes with the Securities and Exchange Commission. Any forward-looking statements
speak only as of the date on which they are made, and the Company undertakes no obligation to publicly update or revise any forward-looking
statements to reflect events or circumstances that may arise after the date of this Current Report on Form 8-K, except as required by
applicable law. Investors should evaluate any statements made by the Company in light of these important factors.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.

| Date: February 13, 2025 | Mustang Bio, Inc. 
 (Registrant)      |                                                      |
|